Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(3 sites)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Mayo Clinic Arizona, Scottsdale, Arizona

Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia